| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $771.9M | +25.6% |
| Cost of Revenue | $271.0M | +14.0% |
| Gross Profit | $500.9M | +33.0% |
| R&D Expense | $263.1M | +29.2% |
| SG&A Expense | $214.5M | +57.7% |
| Operating Income | -$230.0M | -25.8% |
| Pre-tax Income | -$236.8M | -24.0% |
| Income Tax | $2.3M | -44.0% |
| Net Income | -$239.1M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $441.8M | +201.1% |
| Accounts Receivable | $44.5M | +58.6% |
| Current Assets | $572.8M | +129.8% |
| Total Assets | $1.77B | +16.5% |
| Current Liabilities | $153.1M | +22.2% |
| Long-term Debt | $104.0M | -40.4% |
| Total Liabilities | $314.1M | -14.2% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $37.1M | +193.3% |
| Capital Expenditures | $3.8M | -86.6% |
| Investing Cash Flow | -$22.8M | +43.5% |
| Financing Cash Flow | $279.7M | +1052.6% |
| Free Cash Flow | $33.3M | +148.9% |
| -22.5% |
| EPS (Basic) | -$8.53 | -17.8% |
| EPS (Diluted) | -$8.53 | -17.8% |
| Stockholders' Equity |
| $1.45B |
| +404.4% |